Zimmer Biomet Expands Foot and Ankle Portfolio Through Exclusive Global Distribution Agreement with Nextremity Solutions, Inc. (press release)
website Nextremity Solutions
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced an exclusive agreement with Nextremity Solutions, Inc. to globally distribute the company's foot and ankle deformity correction products. The financial terms of the transaction were not disclosed.
"We're excited to expand the clinical capabilities of our foot and ankle portfolio with Nextremity Solutions' deformity correction products," said Brad Quick, General Manager of Zimmer Biomet Foot and Ankle. "The agreement helps advance our commitment to provide customers with the broadest range of cutting-edge technologies and strengthens our position in the $2 billion foot and ankle market."
Nextremity Solutions designs and manufactures the following procedure-ready, sterile implant systems for the correction of foot and ankle pathologies, which will be globally distributed by Zimmer Biomet:
Nextra® Hammertoe Correction System, the industry's only adjustable two-piece hammertoe implant.
MSP™ Metatarsal Sh...
